ATE513056T1 - Stabilisierte proteine - Google Patents

Stabilisierte proteine

Info

Publication number
ATE513056T1
ATE513056T1 AT00973574T AT00973574T ATE513056T1 AT E513056 T1 ATE513056 T1 AT E513056T1 AT 00973574 T AT00973574 T AT 00973574T AT 00973574 T AT00973574 T AT 00973574T AT E513056 T1 ATE513056 T1 AT E513056T1
Authority
AT
Austria
Prior art keywords
polypeptide
tyrosine
cross
tyrosine cross
linking
Prior art date
Application number
AT00973574T
Other languages
English (en)
Inventor
Christopher Marshall
Alexander Hoffman
Joseph Errico
Paul Marshall
Original Assignee
Avatar Medical L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avatar Medical L L C filed Critical Avatar Medical L L C
Application granted granted Critical
Publication of ATE513056T1 publication Critical patent/ATE513056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Head (AREA)
  • Gyroscopes (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00973574T 1999-10-15 2000-10-16 Stabilisierte proteine ATE513056T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15976399P 1999-10-15 1999-10-15
PCT/US2000/028595 WO2001029247A1 (en) 1999-10-15 2000-10-16 Stabilized proteins

Publications (1)

Publication Number Publication Date
ATE513056T1 true ATE513056T1 (de) 2011-07-15

Family

ID=22573921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973574T ATE513056T1 (de) 1999-10-15 2000-10-16 Stabilisierte proteine

Country Status (7)

Country Link
US (3) US7037894B2 (de)
EP (1) EP1282722B1 (de)
AT (1) ATE513056T1 (de)
AU (1) AU1207301A (de)
CA (1) CA2387870C (de)
ES (1) ES2367475T3 (de)
WO (1) WO2001029247A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE513056T1 (de) 1999-10-15 2011-07-15 Avatar Medical L L C Stabilisierte proteine
DE10059720A1 (de) * 2000-11-30 2002-06-06 Roche Diagnostics Gmbh Verwendung intramolekular kovalent vernetzter Proteine als Bindepartner in Immunoassays
EP1641813B1 (de) * 2003-07-03 2011-11-09 Avatar Biotechnologies, Inc. Verfahren zur herstellung von molekülen mit verminderter immunogenität
GB0317304D0 (en) * 2003-07-24 2003-08-27 Hewlett Packard Development Co An analysis apparatus arranged to analyse data and detect change and related methods
US20060275780A1 (en) * 2005-06-06 2006-12-07 Beckman Coulter, Inc. Cross-linking reagents and uses thereof
US8333722B2 (en) * 2005-10-24 2012-12-18 Paul Ewing Communications during rehabilitation
EP1957118B1 (de) * 2005-10-28 2013-06-19 Indian Oil Corporation Limited Verfahren zur biooxidativen desulfurisierung von flüssigen kohlenwasserstoff-brennstoffen und produkt daraus
US8765425B2 (en) 2011-03-23 2014-07-01 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
US8759044B2 (en) 2011-03-23 2014-06-24 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
EP2761677B1 (de) * 2011-09-30 2019-08-21 Microlink Devices, Inc. Durch ein epitaktisches lift-off-verfahren hergestellte lichtemittierende diode
US20130273585A1 (en) * 2012-04-11 2013-10-17 Gangagen, Inc. Soluble cytoplasmic expression of heterologous proteins in escherichia coli
US20130302366A1 (en) * 2012-05-09 2013-11-14 Christopher Marshall Conformationally Specific Viral Immunogens
MX2015017274A (es) 2013-06-14 2016-08-04 Harvard College Moduladores del receptor del polipéptido insulina estabilizados.
JP6685903B2 (ja) * 2013-07-25 2020-04-22 アバター・メディカル・エルエルシー 立体構造的に安定化されたｒｓｖ融合前ｆタンパク質
WO2015020913A2 (en) * 2013-08-03 2015-02-12 Marshall Christopher Patrick Influenza hemagglutinin proteins and methods of thereof
CN106103472A (zh) * 2013-10-01 2016-11-09 哈佛大学的校长及成员们 稳定化的多肽及其用途
CN114805527A (zh) 2014-05-21 2022-07-29 哈佛大学的校长及成员们 Ras抑制肽和其用途
LU92906B1 (en) 2015-12-14 2017-06-20 Luxembourg Inst Science & Tech List Method for enzymatically modifying the tri-dimensional structure of a protein
EP3664836A4 (de) 2017-08-07 2021-05-19 Calder Biosciences Inc. Konformationsstabilisierte rsv-f-präfusionsproteine
MX2020002435A (es) 2017-09-07 2020-09-22 Fog Pharmaceuticals Inc Agentes que modulan las funciones de beta-catenina y sus métodos.
US11623004B2 (en) 2018-03-16 2023-04-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compositions and methods for vaccination against respiratory syncytial virus infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650758A (en) * 1984-09-21 1987-03-17 Cetus Corporation Stabilization of enzymes useful in the production of glucosone and other enzymatic processes
IL83451A (en) * 1987-08-06 1991-06-10 Univ Ramot Stabilized water soluble enzymes and a method for their preparation
US5238831A (en) * 1989-04-28 1993-08-24 Gist-Brocades Stabilization of carboxyl esterase
US5747654A (en) * 1993-06-14 1998-05-05 The United States Of America As Represented By The Department Of Health And Human Services Recombinant disulfide-stabilized polypeptide fragments having binding specificity
ATE513056T1 (de) 1999-10-15 2011-07-15 Avatar Medical L L C Stabilisierte proteine
MXPA01007571A (es) 2000-01-26 2003-06-24 Univ Kansas State Preparacion y uso de polimeros reticulados con peptidos que contienen tirosina.

Also Published As

Publication number Publication date
US20050123530A1 (en) 2005-06-09
EP1282722A1 (de) 2003-02-12
CA2387870A1 (en) 2001-04-26
US7445912B2 (en) 2008-11-04
AU1207301A (en) 2001-04-30
US20020061549A1 (en) 2002-05-23
WO2001029247A1 (en) 2001-04-26
US7037894B2 (en) 2006-05-02
CA2387870C (en) 2012-02-14
EP1282722B1 (de) 2011-06-15
ES2367475T3 (es) 2011-11-03
EP1282722A4 (de) 2004-04-07
US20070184518A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
ATE513056T1 (de) Stabilisierte proteine
DK0973806T3 (da) Sted-beskyttet proteinmodificering
NO990086L (no) Avkortete, l°selige tumornekrosefaktorreseptorer av type I og type II
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
DE69820885D1 (de) Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ATE322503T1 (de) Gefrierschutzprotein
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
DE69731463D1 (de) Rekombinante ribonuklease proteine
DE68927379D1 (de) Plättchen blockierende peptide
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE336256T1 (de) Jodierte proteine zur vorbeugung von jod-mangel zuständen
TR199802584T2 (xx) Denat�re proteinin aktive edilmesi i�in y�ntem.
WO2002044197A3 (en) Cytokine receptor binding peptides
DK39591A (da) Peptidforbindelser
ATE314474T1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE60330680D1 (de) Transferrin-fusionsproteinbibliotheken
ATE432292T1 (de) Antitumorantikörper, proteine und deren verwendung
ATE103930T1 (de) Modifizierte proteine.
NO20014011L (no) Glukosedehydrogenasefusjonsproteiner og deres anvendelse i ekspresjonssystemer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties